SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-009854
Filing Date
2017-05-09
Accepted
2017-05-09 16:11:56
Documents
55
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q fgen-10q_20170331.htm 10-Q 2204417
2 EX-10.26XXXIII fgen-ex1026_231.htm EX-10.26 21182
3 EX-10.32 fgen-ex1032_233.htm EX-10.32 103855
4 EX-10.33 fgen-ex1033_232.htm EX-10.33 104126
5 EX-31.1 fgen-ex311_9.htm EX-31.1 8268
6 EX-31.2 fgen-ex312_6.htm EX-31.2 8262
7 EX-32.1 fgen-ex321_7.htm EX-32.1 7475
8 GRAPHIC g20170509181915313267.jpg GRAPHIC 1854
  Complete submission text file 0001564590-17-009854.txt   6599381

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT fgen-20170331.xml EX-101.INS 1385930
10 XBRL TAXONOMY EXTENSION SCHEMA fgen-20170331.xsd EX-101.SCH 36312
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fgen-20170331_cal.xml EX-101.CAL 49830
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fgen-20170331_def.xml EX-101.DEF 110897
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE fgen-20170331_lab.xml EX-101.LAB 275924
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fgen-20170331_pre.xml EX-101.PRE 218680
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36740 | Film No.: 17826537
SIC: 2834 Pharmaceutical Preparations